NCT04093193

Brief Summary

Functional endoscopic sinus surgery (FESS) is the gold standard surgical intervention for management of patients with chronic rhinosinusitis (CRS). Synechiae formation in the middle meatus is the most common complication of endoscopic sinus surgery after FESS. Nasal debridement is a postoperative procedure used in the prevention of synechiae formation. This procedure lacks standardized evidence-based guidelines. The currently existing studies that have been conducted to determine the efficacy of post-operative debridement have shown conflicting results. We hypothesize that there is no difference in short and long term clinical outcomes between patients who had routine post-operative nasal debridement following FESS and patients who did not have post-operative nasal debridement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2018

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 17, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

September 19, 2019

Status Verified

September 1, 2019

Enrollment Period

3 years

First QC Date

June 7, 2019

Last Update Submit

September 17, 2019

Conditions

Keywords

Functional Endoscopic Sinus Surgery

Outcome Measures

Primary Outcomes (1)

  • Change in Postoperative Synechiae

    The existence of postoperative synechiae will be considered as a categorical, dichotomous outcome variable (presence or absence).

    Day 30, 60, 90, and 180 follow-up visits.

Secondary Outcomes (3)

  • Sinonasal Outcomes Test - 22 (SNOT-22)

    Day 30, 60, 90, and 180 follow-up visits.

  • Philpott-Javer (PJ) and Modified Lund-Kennedy (MLK) Endoscopic Staging System (ESS)

    Day 30, 60, 90, and 180 follow-up visits.

  • Visual Analog Score (VAS) for pain and discomfort

    Day 6, 30, 60, 90, and 180 follow-up visits.

Study Arms (2)

Debridement group

EXPERIMENTAL

Patients receive routine post-operative debridement at their Day 6, 30 and 60 follow up appointments.

Procedure: Debridement

Non Debridement Group

NO INTERVENTION

Patients will not receive debridement at any follow up visit after surgery. They will continue with saline irrigation.

Interventions

DebridementPROCEDURE

Debridement or cleaning of the sinuses post-operatively has been described as a regular post-surgery procedure .

Debridement group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over the age of 19;
  • Have chronic sinus disease (CRS) and are scheduled to undergo sinus surgery on both sides of your nose for the first time.

You may not qualify if:

  • Unable to speak English;
  • Are having surgery for the removal of a nasal tumor;
  • Have a disorder of your immune system in which your body's immune system attacks itself (autoimmune disorder)
  • Diagnosed with cystic fibrosis
  • Have had sinus surgery in the past
  • Are scheduled to have a procedure known as nasal septal reconstruction, without additional sinus surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

E.N.T Clinic, St. Paul's Hospital

Vancouver, British Columbia, V6Z 1Y6, Canada

RECRUITING

Related Publications (16)

  • Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, Jirapongsananuruk O, Kern R, Meltzer EO, Mullol J, Naclerio R, Pilan R, Rhee CS, Suzaki H, Voegels R, Blaiss M. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014 Oct 27;7(1):25. doi: 10.1186/1939-4551-7-25. eCollection 2014.

    PMID: 25379119BACKGROUND
  • Fernandes SV. Postoperative care in functional endoscopic sinus surgery? Laryngoscope. 1999 Jun;109(6):945-8. doi: 10.1097/00005537-199906000-00020.

    PMID: 10369288BACKGROUND
  • Green R, Banigo A, Hathorn I. Postoperative nasal debridement following functional endoscopic sinus surgery, a systematic review of the literature. Clin Otolaryngol. 2015 Feb;40(1):2-8. doi: 10.1111/coa.12330.

    PMID: 25314101BACKGROUND
  • Bednarski KA, Kuhn FA. Stents and drug-eluting stents. Otolaryngol Clin North Am. 2009 Oct;42(5):857-66, x. doi: 10.1016/j.otc.2009.07.001.

    PMID: 19909864BACKGROUND
  • Miller RS, Steward DL, Tami TA, Sillars MJ, Seiden AM, Shete M, Paskowski C, Welge J. The clinical effects of hyaluronic acid ester nasal dressing (Merogel) on intranasal wound healing after functional endoscopic sinus surgery. Otolaryngol Head Neck Surg. 2003 Jun;128(6):862-9. doi: 10.1016/S0194-59980300460-1.

    PMID: 12825038BACKGROUND
  • Saafan ME, Ragab SM, Albirmawy OA, Elsherif HS. Powered versus conventional endoscopic sinus surgery instruments in management of sinonasal polyposis. Eur Arch Otorhinolaryngol. 2013 Jan;270(1):149-55. doi: 10.1007/s00405-012-1969-8. Epub 2012 Apr 10.

    PMID: 22487908BACKGROUND
  • Catalano PJ, Roffman EJ. Evaluation of middle meatal stenting after minimally invasive sinus techniques (MIST). Otolaryngol Head Neck Surg. 2003 Jun;128(6):875-81. doi: 10.1016/S0194-59980300469-8.

    PMID: 12825040BACKGROUND
  • Jorissen M. Postoperative care following endoscopic sinus surgery. Rhinology. 2004 Sep;42(3):114-20.

    PMID: 15521662BACKGROUND
  • Lund VJ, MacKay IS. Outcome assessment of endoscopic sinus surgery. J R Soc Med. 1994 Feb;87(2):70-2. doi: 10.1177/014107689408700204. No abstract available.

    PMID: 8196032BACKGROUND
  • Stammberger H. Endoscopic endonasal surgery--concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg. 1986 Feb;94(2):143-7. doi: 10.1177/019459988609400202.

    PMID: 3083326BACKGROUND
  • Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope. 1992 Dec;102(12 Pt 2 Suppl 57):1-18.

    PMID: 1453856BACKGROUND
  • Bugten V, Nordgard S, Steinsvag S. The effects of debridement after endoscopic sinus surgery. Laryngoscope. 2006 Nov;116(11):2037-43. doi: 10.1097/01.mlg.0000241362.06072.83.

    PMID: 17075402BACKGROUND
  • Bugten V, Nordgard S, Steinsvag S. Long-term effects of postoperative measures after sinus surgery. Eur Arch Otorhinolaryngol. 2008 May;265(5):531-7. doi: 10.1007/s00405-007-0501-z. Epub 2007 Oct 25.

    PMID: 17960410BACKGROUND
  • Alsaffar H, Sowerby L, Rotenberg BW. Postoperative nasal debridement after endoscopic sinus surgery: a randomized controlled trial. Ann Otol Rhinol Laryngol. 2013 Oct;122(10):642-7.

    PMID: 24294687BACKGROUND
  • Nilssen EL, Wardrop P, El-Hakim H, White PS, Gardiner Q, Ogston S. A randomized control trial of post-operative care following endoscopic sinus surgery: debridement versus no debridement. J Laryngol Otol. 2002 Feb;116(2):108-11. doi: 10.1258/0022215021910041.

    PMID: 11827582BACKGROUND
  • Lee JY, Byun JY. Relationship between the frequency of postoperative debridement and patient discomfort, healing period, surgical outcomes, and compliance after endoscopic sinus surgery. Laryngoscope. 2008 Oct;118(10):1868-72. doi: 10.1097/MLG.0b013e31817f93d3.

    PMID: 18641526BACKGROUND

MeSH Terms

Conditions

Disease

Interventions

Debridement

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Central Study Contacts

Amin Javer, MD FRCSCFARS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The patient will know if he/she is getting debridement or not. The PI will comment on all the objective outcome measures and will be the blinded assessor (he will not perform the debridements).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: There will be two possible scenarios resulting from randomization: 1. The patient is randomized to the arm that receives routine post-operative debridement (treatment group). 2. The patient is randomized to the arm that will not receive post-operative debridement (control group).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, St. Paul's Sinus Centre

Study Record Dates

First Submitted

June 7, 2019

First Posted

September 17, 2019

Study Start

June 22, 2018

Primary Completion

July 1, 2021

Study Completion

September 1, 2021

Last Updated

September 19, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be available to other researchers.

Locations